Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Prospective observational study to IDEntify patients with advanced/metastatic NSCLC and ALK and ROS1 translocation and to establish their therapeutic management (IDEALK&ROS)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For ALK Incidence substudy
For the ROS1 treatment sub-study (retrospective only):
Exclusion criteria
692 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal